Story
TPG Explores $5 Billion Sale of Portfolio Company Amid Strong Growth
Summary
Alternative asset manager TPG is reportedly considering a sale of its healthcare software company, Lyric, for up to $5 billion. The potential deal follows a strong quarter of earnings and asset growth, though analysts have recently lowered near-term estimates.
Alternative asset manager TPG Inc. (NASDAQGS: TPG) is reportedly exploring a sale of its healthcare software portfolio company, Lyric, for as much as $5 billion. This potential divestment comes on the heels of a strong second-quarter earnings report and significant growth in the firm's assets under management.
Potential $5 Billion Divestment
According to a September 9 report from Reuters, TPG is considering the sale of Lyric, a healthcare software company in its portfolio. A successful sale near the reported $5 billion figure would represent a significant capital event for the firm, adding to an already strong base of fee-related earnings.
The news follows a period of strong performance for the company. TPG's stock has gained over 11% since the beginning of July, according to data from Investing.com.
Strong Financial Performance
TPG's operational results have been robust, underpinning investor confidence. The firm's second-quarter earnings, reported on August 4, significantly outpaced analyst expectations.
AdKey financial metrics highlighted by Investing.com include:
- Q2 Earnings: Reported earnings per share of $0.82, beating the consensus estimate of $0.60 by nearly 37%.
- Assets Under Management (AUM): Grew 25% year-over-year to reach $327 billion.
- Fee-Related Earnings: Increased by 43% in the second quarter, with fee margins expanding to 50%.
- Valuation: An InvestingPro fair value model suggests a potential upside of 38.2% from the stock's current price, estimating its fair value at $61.82.
Outlook and Analyst Revisions
Investors are now looking ahead to TPG's third-quarter earnings report, which is scheduled for October 29. The current consensus estimate for earnings per share stands at $0.68.
However, the outlook is tempered by recent analyst activity. Data shows 10 downward earnings estimate revisions over the last 90 days, suggesting that some analysts are lowering their near-term expectations. This creates a complex picture for investors, weighing TPG's strong AUM growth and the potential catalyst from the Lyric sale against increased uncertainty surrounding the upcoming earnings announcement.
Read next
More on Stocks
ON Semiconductor Stock Jumps on Revised All-Cash Deal for Synaptics
Shares of the chipmaker surged after it announced a new, cheaper all-cash deal to acquire Synaptics for $5.7 billion, a move that avoids shareholder dilution and is expected to be immediately accretive to earnings.
Schindler Shares Rise as Citi Eyes Positive Catalysts Ahead of Investor Day
Shares in the Swiss elevator and escalator manufacturer gained after analysts at Citi initiated a positive short-term view, citing potential for favorable updates on growth and capital allocation at upcoming company events.
AWS Pledges $1 Billion Investment in US Data Center Communities Amid Local Backlash
Amazon Web Services announced a $1 billion, five-year investment plan for US communities hosting its data centers, aiming to mitigate local concerns over resource consumption and environmental impact.
Capgemini Shares Hit 8-Month High on Positive Sector Cues from Accenture
Shares in the IT services firm surged after competitor Accenture reported stronger-than-expected quarterly results, easing investor concerns about the sector's growth outlook.